Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer [Phase 2]
Phase 2 trial update evaluating ribociclib plus letrozole in relapsed estrogen receptor-positive cancers of female reproductive tract (ovari…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial comparing standard infusion carboplatin to prophylactic extended infusion carboplatin in recurrent ovarian, fallopian tube, …
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating VTX-2337 with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for ganetespib (GANNET53) in metastatic p53-mutant platinum-resistant ovarian cancer; trial terminated with posted res…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating low dose cyclophosphamide with or without nintedanib in advanced ovarian cancer and fallopian tube cancer has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: A Study LY2228820 for Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for LY2228820 in recurrent ovarian cancer (epithelial ovarian cancer, fallopian tube cancer, primary perit…
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer [Phase 2]
Phase 2 trial updating the activity of TroVax versus placebo in relapsed asymptomatic ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with or without pazopanib in persistent or recurrent ovarian, fallopian tube, or peritoneal cavity cance…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy [Phase 2]
Phase 2 clinical trial update for intraperitoneal hyperthermic chemotherapy in several gynecologic and related cancers; current status not s…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating veliparib in patients with persistent or recurrent epithelial ovarian, fallopian tube, or primary perito…
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer [Phase 3]
A Phase 3 trial comparing two first-line regimens (carboplatin-paclitaxel or oxaliplatin-capecitabine) with or without bevacizumab. The stud…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating TRC105 in recurrent ovarian, fallopian tube, or primary peritoneal carcinoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers [Phase 1]
Phase 1 trial update for a vaccine therapy in epithelial ovarian, fallopian tube, or primary peritoneal cancers; trial completed with result…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction [Phase 1, Phase 2]
This Phase 1/2 clinical trial tests best supportive care with either cisplatin or paclitaxel for patients with ovarian cancer, primary perit…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial comparing trabectedin plus doxorubicin liposome vs doxorubicin liposome alone in advanced-relapsed epithelial ovarian, primary…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer [Phase 1]
A Phase 1 trial evaluating a combination chemotherapy approach with bone marrow transplantation and peripheral stem cell transplantation for…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial update for BIBF 1120 in bevacizumab-resistant, persistent, or recurrent epithelial ovarian cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Clinical trial update reporting outcomes on health-related quality of life and symptoms for patients recovering from major gynecologic cance…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and pemetrexed in recurrent platinum-sensitive ovarian cancer completed.
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) [Phase 3]
Phase 3 trial (ARIEL3) evaluating rucaparib as switch maintenance after platinum in relapsed high-grade serous or endometrioid ovarian cance…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients [Phase 1]
Phase 1 study evaluating docetaxel in combination with PTK787 in metastatic breast cancer and gynecologic cancers; the trial conducted by Da…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 study evaluating NY-ESO-1 overlapping peptides in epithelial ovarian, fallopian tube, or primary peritoneal cancer completed with re…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer [Phase 2]
A Phase 2 trial of CRLX101 in combination with Bevacizumab for recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without everolimus in recurrent ovarian epithelial cancer, fallopian tube cancer, or primary pe…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer [Phase 2]
Phase 2 trial update of alisertib (MLN8237) in ovarian, fallopian tube, or peritoneal cancer following a prior MLN8237 plus paclitaxel Phase…